Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The incidence of ampulla of Vater carcinoma, a type of periampullary cancer, has been increasing at an annual percentage rate of 0.9%. However, patients with ampulla of Vater carcinoma have quite different prognoses due to the heterogeneities of the tissue origin of this carcinoma. In addition to TNM staging, histological subtypes and molecular features of ampulla of Vater carcinoma are the key factors for predicting the clinical outcomes of patients. Fortunately, with the development of testing technology, information on the histological subtypes and molecular features of ampulla of Vater carcinoma is increasingly being analyzed in-depth. Patients with the pancreaticobiliary subtype have shorter survival times. In immunohistochemical examination, high cutoff values of positive MUC1 staining can be used to accurately predict the outcome of patients. Mutant , , negative expression, and microsatellite stability are related to poor prognosis, while the clinical value of mutations is limited for prognosis. Testing the histological subtypes and molecular characteristics of ampulla of Vater carcinoma not only is the key to prognosis analysis but also provides extra information for targeted treatment to improve the clinical outcomes of patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233008 | PMC |
| http://dx.doi.org/10.3389/fonc.2023.1135324 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Nationwide Survey on Endoscopic Papillectomy for Ampullary Adenoma: Current Practices and Variability.
Gut Liver
September 2025
Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
Background/aims: Ampullary adenomas are precancerous lesions requiring accurate diagnosis and timely intervention to prevent malignant transformation. Endoscopic papillectomy (EP) has emerged as a less invasive alternative to surgery; however, technical variations in practice remain. This study evaluated contemporary real-world approaches to the diagnosis, treatment, and surveillance of ampullary adenomas among pancreatobiliary endoscopists.
View Article and Find Full Text PDFCase Report: Late simultaneous metastasis of renal clear cell carcinoma to the ampulla and breast.
Front Oncol
August 2025
Department of Thyroid and Breast Surgery, The Fourth People's Hospital of Jinan, Jinan, China.
We present the case of a 67-year-old female who developed simultaneous metastases to the ampulla of Vater and the breast. Her medical history is significant for a radical nephrectomy performed twenty-one years prior for renal cell carcinoma (RCC). The patient was referred for evaluation due to the development of progressive jaundice, fatigue, and weight loss.
View Article and Find Full Text PDFHistopathologic discrepancies between endoscopic forceps biopsy and resection specimens in duodenal papillary lesions: a retrospective study.
BMC Gastroenterol
September 2025
Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, P.R. China.
Background: Endoscopic papillectomy (EP) has been used for the treatment of duodenal papillectomy, and the results of preoperative endoscopic biopsy are important for the selection of treatment plans for the patients. However, some lesions cannot be precisely diagnosed based solely on biopsy results. In the study, we attempted to assess the accuracy of histopathological diagnosis of endoscopic forceps biopsy and to avoid over - or under-treatment.
View Article and Find Full Text PDFComparison of Frontline FOLFIRINOX with Fluorouracil-Based and Gemcitabine-Based Chemotherapies in Metastatic Ampullary Adenocarcinoma: A Multicenter Study by the Turkish Oncology Group (TOG).
J Clin Med
August 2025
Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06800, Turkey.
Adenocarcinoma arising from the ampulla of Vater is an extremely rare neoplasm, and there are limited data regarding frontline therapy for metastatic disease. We investigated the outcomes of first-line treatment with FOLFIRINOX by comparing it with other treatments in patients with advanced ampullary adenocarcinoma. We included 123 patients with advanced ampullary adenocarcinoma who were treated with frontline FOLFIRINOX ( = 32), fluorouracil (FU)-based chemotherapy ( = 20), and gemcitabine-based chemotherapy ( = 65) between August 2007 and January 2024 in this retrospective study.
View Article and Find Full Text PDFLong-term disease-free survival of a patient diagnosed with peri-ampullary carcinoma treated with adjunct Ayurvedic treatment - A case report.
J Ayurveda Integr Med
August 2025
Bharatiya Sanskriti Darshan Trust's Integrated Cancer Treatment and Research Centre, Wagholi, Pune, Maharashtra, India.
This is a case of a female Indian patient diagnosed as Peri-Ampullary Carcinoma, with metastasis to regional lymph nodes, and reported 5-year disease free survival rate of 20-50%, treated with integration of personalized Ayurvedic treatment along with conventional treatments viz., surgery and adjuvant chemotherapy. The patient was diagnosed with adenocarcinoma through biopsy from the ampulla of Vater during registration at our Centre in May 2010.
View Article and Find Full Text PDF